SMALL MACHINES
SMALLMACHINES is a digital healthcare company providing personalized medical platforms under universal healthcare benefits. It develops advanced medical diagnostic devices including CELLOP, an image-based automatic cell analyzer offering comprehensive cell information; DELISA, a high-sensitivity multiplex immunoassay analyzer using magnetic particle technology for biomarkers like Vitamin D and Alzheimer's; WHOPE, a general blood test device using small capillary blood samples; CHIP, a microfluidic chip for rapid and accurate point-of-care testing (POCT); and CDSS, a clinical decision support system aiding medical professionals in diagnosis and treatment decisions based on patient clinical data. The company integrates cutting-edge technologies such as lab-on-a-chip semiconductor microfabrication, Fourier Ptychography Microscopy optics, magnetic bead-based bio-protocols, and AI for ultra-high resolution single-cell image analysis. SMALLMACHINES has completed Series A bridge investment and collaborates with research institutes and healthcare organizations, positioning itself as an innovator in future medical services with a total digital healthcare solution.
SMALL MACHINES
SMALLMACHINES is a digital healthcare company providing personalized medical platforms under universal healthcare benefits. It develops advanced medical diagnostic devices including CELLOP, an image-based automatic cell analyzer offering comprehensive cell information; DELISA, a high-sensitivity multiplex immunoassay analyzer using magnetic particle technology for biomarkers like Vitamin D and Alzheimer's; WHOPE, a general blood test device using small capillary blood samples; CHIP, a microfluidic chip for rapid and accurate point-of-care testing (POCT); and CDSS, a clinical decision support system aiding medical professionals in diagnosis and treatment decisions based on patient clinical data. The company integrates cutting-edge technologies such as lab-on-a-chip semiconductor microfabrication, Fourier Ptychography Microscopy optics, magnetic bead-based bio-protocols, and AI for ultra-high resolution single-cell image analysis. SMALLMACHINES has completed Series A bridge investment and collaborates with research institutes and healthcare organizations, positioning itself as an innovator in future medical services with a total digital healthcare solution.